Domov › Bipolarna motnja › Illinois
Klinične študije za Bipolarna motnja v Illinois
7 študij za Bipolarna motnja išče udeležence na lokacijah v Illinois.
Mesta v Illinois
Uradno besedilo študije (angleško)
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Baber Research Group, Naperville
Vključevanje udeležencevFaza 3
Starost 5–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
- Revive Research Institute, Elgin
Vključevanje udeležencevFaza 3
Starost 10–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06372964A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Revival Research Institute, Elgin
- Advanced Quality Medical Research, Orland Park
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Pillar Clinical Research - Chicago /ID# 272823, Chicago
- Amr Conventions Research /ID# 272867, Warrenville
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT06696755A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Pillar Clinical Research -Chicago, Chicago
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07140913Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
Vključevanje udeležencevOpazovalna študija
Starost 18–40 · Vsi spoli · Posodobljeno 10. mar. 2026 · NCT06740383Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.